Baxter International operates globally across three primary segments: Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The company's product line includes IV fluids, infusion pumps, surgical sealants, inhaled anesthetics, and patient monitoring technologies. In 2021, Baxter expanded its hospital-focused offerings by acquiring Hillrom, adding smart beds and diagnostic equipment to its portfolio. In early 2025, the company completed the divestiture of its Kidney Care business, Vantive, to concentrate on its core hospital and medication delivery products. Baxter distributes its products through a direct sales force, independent distributors, and drug wholesalers across more than 100 countries.
